Contact
Please use this form to send email to PR contact of this press release:
Evoke Pharma’s Phase 3 Results for Gimoti Accepted as Late-Breaker for Presentation at Digestive Disease Week 2017
TO:
Please use this form to send email to PR contact of this press release:
Evoke Pharma’s Phase 3 Results for Gimoti Accepted as Late-Breaker for Presentation at Digestive Disease Week 2017
TO: